Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Blog updated 12/22/2022
Blog updated 12/22/2022
Blog updated 10/04/2022
Resource updated 03/15/2023
Blog updated 08/19/2022
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 05/15/2024
Resource updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
RWHAP Technical Assistance Provider updated on 03/06/2024
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 02/20/2024
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023
Overview of successes and challenges of implementing a sliding fee scale and an efficient cap-on-charges process by a RWHAP clinic.
Resource (Conference Presentation) updated 09/14/2023
RWHAP Technical Assistance Provider updated on 05/24/2024